CCR has established a unique and exciting partnership with Rockland Immunochemicals to produce rabbit polyclonal antibodies against key cancer targets of interest to CCR - at no cost to individual investigators. A list of antigens is now being compiled that includes: (1) novel candidate proteins for which no commercially available antibodies exist; (2) known proteins for which commercially available antibodies exist but fail to meet investigators' requirements; and (3) proteins with phosphorylation sites that may be of importance in activation pathways. Proposals submitted by CCR PI’s will be reviewed and prioritized by CCR and Rockland.

For more information on this unique opportunity, please contact:

Shoshana Segal, Ph.D.
E-mail: shosh@nih.gov
Telephone: 301-496-0923
Assistant Director for Technology Development
Office of Science and Technology Partnerships
Office of the Director, CCR